J.P. Neijt

3.6k total citations · 1 hit paper
33 papers, 2.5k citations indexed

About

J.P. Neijt is a scholar working on Reproductive Medicine, Oncology and Surgery. According to data from OpenAlex, J.P. Neijt has authored 33 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Reproductive Medicine, 17 papers in Oncology and 6 papers in Surgery. Recurrent topics in J.P. Neijt's work include Ovarian cancer diagnosis and treatment (20 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Cancer Treatment and Pharmacology (6 papers). J.P. Neijt is often cited by papers focused on Ovarian cancer diagnosis and treatment (20 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Cancer Treatment and Pharmacology (6 papers). J.P. Neijt collaborates with scholars based in Netherlands, Belgium and Germany. J.P. Neijt's co-authors include JCJM de Haes, A.T. van Oosterom, Hans C. van Houwelingen, M. van Lent, A.C.M. van Lindert, W W ten Bokkel Huinink, W.W. ten Bokkel Huinink, Pax H.B. Willemse, M E van der Burg and A. Peter M. Heintz and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

J.P. Neijt

33 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist

1990 722 citations JCJM de Haes, J.P. Neijt et al. British Journal of Cancer profile →

Peers

J.P. Neijt

ONCOL

SURGE

PRM

P M Wilkinson United Kingdom

Mison Chun South Korea

Adnan Aydıner Türkiye

Marian J.E. Mourits Netherlands

Janardan D. Khandekar United States

Julian C. Schink United States

Anna K.L. Reyners Netherlands

Therese B. Bevers United States

William J. Huster United States

Willi Oberaigner Austria

P M Wilkinson United Kingdom

J.P. Neijt

1.0k ×0.9

ONCOL

603 ×0.7

1.2k ×1.5

SURGE

799 ×1.8

PRM

124 ×0.4

Citations per year, relative to J.P. Neijt J.P. Neijt (= 1×) peers P M Wilkinson

Countries citing papers authored by J.P. Neijt

Since Specialization

Citations

This map shows the geographic impact of J.P. Neijt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Neijt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Neijt more than expected).

Fields of papers citing papers by J.P. Neijt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Neijt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Neijt. The network helps show where J.P. Neijt may publish in the future.

Co-authorship network of co-authors of J.P. Neijt

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Neijt. A scholar is included among the top collaborators of J.P. Neijt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Neijt. J.P. Neijt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Quinn, Michael, E. Åvall‐Lundqvist, Andreas du Bois, et al.. (2005). History, scope and methodology of the 3rd International Consensus Workshop on Ovarian Cancer 2004. Annals of Oncology. 16. viii5–viii6. 5 indexed citations

Kappen, Hilbert J., et al.. (2002). ”PROMEDAS” : a probabilistic decision support system for medical diagnosis. Data Archiving and Networked Services (DANS). 10 indexed citations

Eisenhauer, Elizabeth A., Martin Gore, & J.P. Neijt. (1999). Ovarian cancer: should we be managing patients with good and bad prognostic factors in the same manner?. Annals of Oncology. 10. S9–S15. 42 indexed citations

Bois, Andreas du, J.P. Neijt, & J.T. Thigpen. (1999). First line chemotherapy with carboplatin plus paclitaxel in advanced ovarian cancer--a new standard of care?. Annals of Oncology. 10(1). 35–41. 72 indexed citations

Bois, Andreas du, J.P. Neijt, & J.T. Thigpen. (1999). First line chemotherapy with carboplatin plus paclitaxel in advanced ovarian cancer - a new standard of care?. Annals of Oncology. 10. S35–S41. 22 indexed citations

Wit, Ronald de, G. Stoter, J.P. Neijt, et al.. (1998). Four cycles of BEP vs four cycles of VIP in patients with intermediate-prognosis metastatic testicular non-seminoma: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group. British Journal of Cancer. 78(6). 828–832. 90 indexed citations

Hansen, Heine H., Elizabeth A. Eisenhauer, M Hansen, et al.. (1993). New cytostatic drugs in ovarian cancer. Annals of Oncology. 4. S63–S70. 20 indexed citations

Kroon, Hidde M., O. L. M. Bijvoet, F. J. Cleton, et al.. (1993). Palliative pamidronate treatment in patients with bone metastases from breast cancer.. Journal of Clinical Oncology. 11(3). 491–498. 164 indexed citations

Taal, B.G., Riccardo A. Audisio, Harry Bleiberg, et al.. (1993). Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study. Annals of Oncology. 4(7). 607–609. 58 indexed citations

10.

Aalders, J.G. & J.P. Neijt. (1993). Aspects of surgery in ovarian and endometrial carcinoma. European Journal of Cancer. 29(4). 624–628. 3 indexed citations

11.

Neijt, J.P., W.W. ten Bokkel Huinink, M.E.L. van der Burg, et al.. (1991). Long-term survival in ovarian cancer. European Journal of Cancer and Clinical Oncology. 27(11). 1367–1372. 175 indexed citations

12.

Oosterom, A.T. van, W.W. ten Bokkel Huinink, M.E.L. van der Burg, et al.. (1991). Phase II clinical trial of doxifluridine in patients with advanced ovarian cancer. European Journal of Cancer and Clinical Oncology. 27(6). 747–749. 9 indexed citations

13.

Haes, JCJM de, et al.. (1990). Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. British Journal of Cancer. 62(6). 1034–1038. 722 indexed citations breakdown →

14.

Voest, Emile E., Hans C. van Houwelingen, & J.P. Neijt. (1989). A meta-analysis of prognostic factors in advanced ovarian cancer with median survival and overall survival (measured with the log (relative risk)) as main objectives. European Journal of Cancer and Clinical Oncology. 25(4). 711–720. 79 indexed citations

15.

Neijt, J.P., M.E.L. van der Burg, Jean‐Paul Guastalla, et al.. (1989). Phase Ii Trial of Mitozolomide in Patients with Advanced Ovarian Cancer: A Study of the Eortc Gynecological Cancer Cooperative Group. Acta Oncologica. 28(5). 663–665. 4 indexed citations

16.

Neijt, J.P., et al.. (1989). The bioavailability of three altretamine formulations. Pharmacy World & Science. 11(6). 218–223. 4 indexed citations

17.

Houwelingen, Hans C. van, W.W. ten Bokkel Huinink, M E van der Burg, A.T. van Oosterom, & J.P. Neijt. (1989). Predictability of the survival of patients with advanced ovarian cancer.. Journal of Clinical Oncology. 7(6). 769–773. 79 indexed citations

18.

Bijvoet, O. L. M., J. Hermans, H.I.J. Harinck, et al.. (1987). REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENT. The Lancet. 330(8566). 983–985. 162 indexed citations

19.

Huinink, W W ten Bokkel, R. Vriesendorp, A.T. van Oosterom, et al.. (1987). Teniposide (VM-26) in patients with advanced refractory ovarian cancer: a phase II study of the Netherlands joint study group for ovarian cancer. European Journal of Cancer and Clinical Oncology. 23(7). 997–998. 2 indexed citations

20.

Neijt, J.P., A.C.M. van Lindert, C. P. J. Vendrik, et al.. (1980). Treatment of advanced ovarian carcinoma with a combination of hexmethylmelamine, cyclophosphamide, methotrexate, and 5-fluorourcil (hexa-CAF) in patients with and without previous treatment.. PubMed. 64(2-3). 323–6. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact